Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 481 of 1,261
  1. US 10378014

    Compositions and methods for the treatment of influenza infection

    Lakewood Amedex, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  2. US 10377817

    Human antibodies to GREM1

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  3. US 10378058

    Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer

    The Board of Regents of the University of Texas System · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  4. US 10377796

    Inhibition of pulmonary fibrosis with nutlin-3a and peptides

    The Board of Regents of the University of Texas System · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  5. US 10377801

    Amelioration of chronic kidney disease

    Northwestern University · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  6. US 10377772

    Macrocyclic LRRK2 kinase inhibitors

    Oncodesign SA · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  7. US 10377751

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  8. MA 46343

    SCHÉMA POSOLOGIQUE POUR UN COMPOSÉ DE PTH À LIBÉRATION CONTRÔLÉE

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Aug 7, 2019 · Expires Aug 2, 2039

    granted
  9. US 10369201

    Methods and compositions for treating Huntington's disease

    Sangamo Therapeutics, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  10. US 10369224

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  11. US 10370679

    Modified immunization vectors

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  12. US 10370449

    Methods for treating skin infection by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  13. US 10370366

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  14. US 10369141

    Methods of improving cell-based therapy

    The Regents of the University of California · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  15. US 10370360

    Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  16. US 10369173

    Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

    Capricor, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  17. US 10369158

    Pharmaceutical packaging for estriol therapy

    The Regents of the University of California · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  18. US 10370333

    Sulfonamide compounds and uses as TNAP inhibitors

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  19. US 10370348

    Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  20. US 10370361

    Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

    DENALI THERAPEUTICS INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  21. US 10370349

    Functionalised benzopyran compounds and use thereof

    Kazia Therapeutics Limited · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  22. US 10370345

    Amyloid targeting agents and methods of using the same

    The Regents of the University of California · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  23. US 10369226

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  24. US 10369229

    Methods and compositions for liposomal formulation of antigens and uses thereof

    The Regents of the University of California · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.